Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service

XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service

XMax Inc. announced it has signed multiple AI API service contracts worth up to approximately $25 million, highlighting strong commercial adoption of its AI platform. Additionally, the company has entered the GPU-as-a-Service market, offering dedicated GPU computing resources to enterprise customers, integrating AI model API services with GPU infra…

dLocal added to membership of US small-cap Russell 2000® Index

dLocal added to membership of US small-cap Russell 2000® Index

dLocal Limited, a cross-border financial infrastructure platform, announced its inclusion in the US small-cap Russell 2000® Index effective June 29, 2026. Being part of this renowned index reflects the company's market capitalization, scale, and free float, and is expected to improve trading liquidity, broaden its shareholder base, and increase ins…

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

Matinas BioPharma Holdings, Inc. announced it received a notice from NYSE American indicating non-compliance with certain listing standards related to minimum stockholders' equity and sustained losses. The exchange accepted the company's submitted plan to regain compliance by October 2, 2027, allowing the company to maintain its listing during the …

Record Trading Volume on the Nasdaq Closing Cross During the June 2026 Russell US Indexes Reconstitution

Record Trading Volume on the Nasdaq Closing Cross During the June 2026 Russell US Indexes Reconstitution

Nasdaq announced a record trading day with 4.59 billion shares worth $334 billion executed in the Nasdaq Closing Cross during the June 2026 Russell US Indexes reconstitution. This milestone surpasses previous years and highlights Nasdaq's advanced infrastructure facilitating efficient and precise market closing processes amid increasing volume and …

Helport AI Reports First Half Fiscal Year 2026 Financial Results

Helport AI Reports First Half Fiscal Year 2026 Financial Results

Helport AI Limited announced its unaudited financial results for the first half of fiscal year 2026, reporting a 7.7% increase in revenue to $17.7 million, driven by rising enterprise adoption of its AI Labor System and AI-powered customer engagement solutions. Despite a net loss of $1.7 million due to increased R&D expenses and credit losses, the …

WeRide Inc. Announces Results of Annual General Meeting

WeRide Inc. Announces Results of Annual General Meeting

WeRide Inc., a global autonomous driving technology leader, announced the successful adoption of all proposed resolutions at its Annual General Meeting held in Guangzhou. Key approvals include the re-election of all nominated directors, grants of general unconditional mandates to issue new shares, and to repurchase shares and ADSs, supporting the c…

FutureFuel Announces Director Resignation

FutureFuel Announces Director Resignation

FutureFuel Corp. disclosed that Paul M. Manheim, a long-serving board member and chair of the Audit Committee, will retire from the Board effective after the 2026 annual meeting. This resignation was not due to any disagreement with the company. Consequently, the Board will reduce its size from nine to eight members and is reviewing its committee c…

Kite Realty Group Completes Sale of City Center

Kite Realty Group Completes Sale of City Center

Kite Realty Group (NYSE: KRG) announced the successful sale of City Center, a mixed-use asset in White Plains, New York, for $50 million. This sale advances its capital recycling goals and aligns with previously shared plans. The company will detail use of proceeds and future capital allocation plans in the upcoming earnings call. With a focus on h…

Kite Realty Group Publishes Annual Corporate Responsibility Report

Kite Realty Group Publishes Annual Corporate Responsibility Report

Kite Realty Group, a real estate investment trust specializing in open-air shopping centers and mixed-use assets, published its 2025 Corporate Responsibility Report detailing its strategies, initiatives, and progress on corporate responsibility. The report underscores the company’s commitment to sustainability and stakeholder value across its U.S.-…

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Larimar Therapeutics announced an upcoming investor webcast to share updates on their nomlabofusp clinical program for treating Friedreich’s ataxia. The event will cover regulatory progress and data from ongoing long-term studies. The company is focused on developing treatments for rare diseases and is advancing nomlabofusp towards regulatory submi…

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Monopar Therapeutics announced new analyses from their Phase 3 FoCus trial demonstrating that ALXN1840 provides significant neurologic and global clinical improvements over standard of care for Wilson Disease patients with neurological symptoms. The data supports a planned FDA New Drug Application submission in mid-2026, highlighting ALXN1840's str…

Alpex Acquisition Corporation Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Over-allotment Option

Alpex Acquisition Corporation Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Over-allotment Option

Alpex Acquisition Corporation, a Cayman Islands exempted blank check company, has successfully closed its initial public offering of 11.5 million units at $10 per unit, including the full exercise of the underwriters' over-allotment option. Gross proceeds totaled $115 million before expenses, with net proceeds held in trust pending a future busines…

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Universe Pharmaceuticals INC, a Nasdaq-listed pharmaceutical company based in China, announced the strategic acquisition of Best Praise International Limited, a company holding five patents related to age-related diseases, neurodegenerative conditions, cardiovascular pharmaceuticals, antibacterial compounds, and drug delivery technologies. The acqu…

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

Ascendis Pharma has been added to the broad-market Russell 3000® Index, the Russell 1000®, Russell 2500®, and Russell Midcap® Indexes during the 2026 semi-annual Russell U.S. Indexes reconstitution, reflecting its growing market capitalization and presence in U.S. equity markets. This inclusion is significant as these indexes are widely used benchm…